Acute Myeloid Leukemia (Acute Myelogenous Leukemia) Summary

Networked: 14185 relevant articles (1624 outcomes, 1882 trials/studies) for this Disease

Key Drugs and Agents for Acute Myeloid Leukemia

1. Cytarabine (Cytosar-U) : 264 outcomes 291 studies in 1424 results : FDA 13 Generic
   
2. Daunorubicin (Cerubidine) : 70 outcomes 90 studies in 400 results : FDA 8 Generic
   
3. Cyclophosphamide (Cytoxan) : 53 outcomes 19 studies in 174 results : FDA 10 Generic
   
4. Etoposide (VP 16) : 47 outcomes 74 studies in 310 results : FDA 16 Generic
   
5. Granulocyte Colony-Stimulating Factor (G-CSF) : 44 outcomes 55 studies in 365 results : IBA
   
6. fludarabine : 38 outcomes 31 studies in 188 results : IBA
   
7. Mitoxantrone (Novantrone) : 37 outcomes 73 studies in 245 results : FDA 8 Generic
   
8. Interleukin-2 (IL2) : 37 outcomes 23 studies in 107 results : IBA
   
9. Busulfan (Busulfex) : 34 outcomes 12 studies in 115 results : FDA 2
   
10. gemtuzumab (gemtuzumab ozogamicin) : 30 outcomes 53 studies in 201 results : FDA 1
    

Diseases Related to Acute Myeloid Leukemia

1. Leukemia
2. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
3. Myelodysplastic Syndromes (Myelodysplastic Syndrome)
4. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
5. BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)

Key Therapies for Acute Myeloid Leukemia

1. Drug Therapy (Chemotherapy) : 474 outcomes 321 studies in 2418 results
   
2. Bone Marrow Transplantation (Transplantation, Bone Marrow) : 170 outcomes 53 studies in 594 results
   
3. Transplants (Transplant) : 123 outcomes 48 studies in 496 results
   
4. Transplantation (Transplant Recipients) : 99 outcomes 42 studies in 425 results
   
5. Stem Cell Transplantation : 82 outcomes 46 studies in 396 results